This document is a publication of a European Patent Office (EPO) patent application, specifically EP2026030538A1, titled "CD84+/MERTK+ MYELOID DERIVED SUPPRESSOR CELLS AND METHODS OF USE FOR TRANSPLANTATION TOLERANCE." The publication date is March 18, 2026. It details methods and compositions involving specific types of myeloid-derived suppressor cells for achieving transplantation tolerance.

As this is a patent application publication, it does not impose direct compliance obligations on regulated entities. However, it signifies potential future intellectual property rights and technological advancements in the field of transplantation and immunotherapy. Companies operating in the biotechnology and pharmaceutical sectors should be aware of this publication as it may impact their research, development, and commercialization strategies related to cell therapies and immune tolerance.